ArticleNature communications2025
Enzymatically reconfigurable liquid crystalline coacervate microdroplets as protocell models.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Colon-targeting pH-responsive Bletilla striata polysaccharide coacervate microdroplets for ulcerative colitis therapy via macrophage reprogramming.Journal of nanobiotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Reconfigurable cell-sized compartments can act as artificial cellular models that dynamically respond to environmental stimuli, mimicking the adaptive behaviors of living cells. In this study, we present enzymatically active liquid crystalline (LC) coacervate microdroplets as a protocell model, which undergoes differentiation into helicoidal vesicles and eventually membranous protocells containing artificial organelles. The LC protocell microdroplets are developed through electrostatic complexation between a negatively charged polysaccharide and a cationic surfactant. We identify the amylase-mediated hydrolysis of polysaccharide as the molecular mechanism that is accounted for two-step structural changes of protocells, in which electrostatic complexation plays a crucial role. Notably, by integrating affinitive biomolecules into the LC microdroplets, we demonstrate the reconfiguration of protocells into yolk-shell coacervate vesicles that support biochemical reactions. Our findings illustrate the potential to build protocell models to mimic the differentiation behaviors of cellular materials and shed light to the understanding of the structural reconfiguration of protocells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.